
Bausch Health Companies Inc.
NYSE · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Bausch Health Companies Inc. develops, manufactures, and markets pharmaceutical products, medical devices, and over-the-counter products across eye care, gastroenterology, dermatology, and neurology, including its Bausch + Lomb eye health business.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Lenar Aimee J.President, US Pharma | Sell | $259K | 36,827at $7.03 | Aug 19, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable BHC activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.